Skip to main content

Table 1 Demographic, clinical and virological features of the study patients

From: Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations

Patient Age
(yrs)
Gender* Time of
Infection
(yrs)
Total time on
HAART
(yrs)
NADIR CD4
(cells/microliter
CD4
T0**
(cells/microliter)
HIV-RNA
T0**
(Log10cp/ml)
CD4
T1***
(cells/microliter)
HIV-RNA
T1***
(Log10cp/ml)
Pt.1 48 F 18 6 312 569 <1.7 598 3,30
Pt.2 37 M 11 10 438 1093 <1.7 1162 1,92
Pt.3 52 M 8 7 336 699 <1.7 520 > 5,70
Pt.4 41 M 10 9 246 697 <1.7 428 5,25
Pt.5 50 F 17 9 223 792 <1.7 511 5,60
  1. * M, male; F, female.
  2. ** T0: at the time of HAART interruption
  3. *** T1: one month after HAART interruption